Digital twins of your study patients enable more informed go/no decisions that save resources and fast-track the most promising therapies
Digital twins of your study patients enable more informed go/no decisions that save resources and fast-track the most promising therapies
We work in neuroscience, immunology, metabolic disease, and more.
Discover how the Unlearn Platform can enhance your trial’s efficiency, insights, and impact, tailored to your needs. Explore a few of our solutions below and book a demo to learn how we can support your trial goals.
Explore a few of our AI-driven solutions below and get in touch to discuss how we can support your study.
Design and run smaller RCTs that maintain power or boost it without additional study participants. This approach is qualified by the EMA and aligns with current FDA guidance.
Explore predicted outcomes for any subgroup of participants for all measured clinical outcomes at any point in time. This capability supports interim analyses and other critical decisions throughout your study.
Use digital twins to refine inclusion/exclusion criteria and clinical endpoints, enabling more efficient trials with a higher chance of success.
Disease-specific ML models trained on extensive historical clinical data generate digital twins for each trial participant using only their baseline data.
Every clinical outcome at every future time point.
Predicted with unparalleled precision.
These twins forecast clinical outcomes at every future time point.
Predicted with unparalleled precision.
Explore how leading biopharma companies are applying Unlearn’s technology in real-world clinical trials today.